低氧介导的m6在肝细胞癌中的调节:一个全面的审查
Hai-Tao Jiang1, Shi-Yi Qian2, Pin-Ru Di2
1Department of General Surgery, Ningbo No.2 Hospital, Ningbo, 315000, Zhejiang Province, China. jht5019@aliyun.com.
Journal of translational medicine
|November 4, 2025
概括
缺氧-m6A轴影响肝细胞癌 (HCC) 的进展和治疗耐药性. 针对这一轴,为先进的HCC提供新的治疗策略,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,预后不佳,特别是在肝硬化患者中.
- 在HCC中缺氧瘤微环境与针对性和免疫疗法的反应不佳相关.
- N6-甲基氨酸 (m6A) 的表观遗传修饰与瘤免疫逃避,代谢重编程和铁灭菌耐药性有关.
研究的目的:
- 为了阐明低氧-m6A轴在HCC进展中的分子机制.
- 探索缺氧-m6A轴作为HCC的生物标志物和治疗点的临床潜力.
- 讨论目前的局限性和未来的研究方向,以针对HCC的这一轴.
主要方法:
- 对涉及缺氧诱导因子 (HIF-1α) 和m6A修饰酶 (METTL3,FTO,YTHDF2) 的分子机制的系统审查.
- 在HCC中低氧和m6A修饰之间的相互作用的分析.
- 作为治疗点的缺氧-m6A轴的临床观点.
主要成果:
- 低氧诱导因子 (HIF-1α) 和关键的m6A酶 (METTL3,FTO,YTHDF2) 在低氧微环境中共同调节HCC的进展.
- 低氧-m6A轴在瘤免疫逃避,代谢重编程和HCC中的铁灭性抵抗中起着至关重要的作用.
- 有证据表明,缺氧-m6A轴是克服HCC治疗耐药性的有希望的生物标志物和治疗标.
结论:
- 缺氧-m6A轴为管理HCC提供了新的治疗前景.
- 针对这一轴可以克服先进的HCC的治疗阻力.
- 未来的研究应该专注于先进的纳米药物,免疫检查点抑制剂和多模式成像用于个性化HCC治疗.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:23Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K